Search Results for 'abbott'
-
-
Software & IT
Abbott to Sell STARLIMS Informatics Suite to Francisco Partners
STARLIMS manages collection, processing, storage, retrieval, and analysis of info generated in labs.Business Wire 07.08.21
-
Cardiovascular
Abbott's Xience Stent Gets New Labeling Approval
FDA approval for shortest blood thinner course for high bleeding risk patients.Abbott Laboratories 06.30.21
-
Diagnostics
Abbott's Panbio Rapid COVID-19 Antigen Self-Test Earns EU Approval
Approved for sale directly to consumers and for use in adults and children with or without symptoms.Abbott Laboratories 06.28.21
-
Abbott Engages in STEM Internships for College Credit
First-of-its-kind college credit opportunity provides model other companies can follow to give students a head start on earning STEM degrees.PR Newswire 06.22.21
-
Cardiovascular
Abbott Recalls Assurity, Endurity Pacemakers
Potential moisture ingress is causing electrical shorts and reduced battery life.Sam Brusco, Associate Editor 05.17.21
-
Cardiovascular | Surgical
Abbott's Navitor TAVI System Gains CE Mark
The new TAVI system features advancements to reduce or eliminate risk of blood leakage around valve implant.Sam Brusco, Associate Editor 05.17.21
-
Cardiovascular | Patient Monitoring
Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure
Will use cardiac ablation and sensors to monitor pulmonary artery pressure and abnormal heartbeats.Sam Brusco, Associate Editor 05.06.21
-
Diagnostics
Abbott Begins Shipping Rapid COVID Self-Tests
Abbott to manufacture tens of millions of BinaxNOW Self Tests per month.Sam Brusco, Associate Editor 04.20.21
-
Cardiovascular | Surgical
Abbott's Next-Gen TriClip Earns EU Nod
New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve.Sam Brusco, Associate Editor 04.08.21
-
Diagnostics
Abbott's Rapid COVID-19 Self-Test Receives EUA
Permits asymptomatic, non-prescription, over-the-counter self-use for people with or without symptoms.Sam Brusco, Associate Editor 04.01.21
-
Neurological
Abbott Releases NeuroSphere Virtual Clinic for Remote Neuromodulation Care
Patients can communicate with a physician and remotely receive stimulation settings in real-time with a web connection.Videos Sam Brusco, Associate Editor
-
Diagnostics
Abbott's Panbio Rapid COVID-19 Antigen Test Earns CE Mark for Two New Uses
EU approves symptomatic screening and self-administered sample collection with nasal swab.Sam Brusco, Associate Editor 01.26.21
-
Cardiovascular | Surgical
Abbott Wins Expanded Medicare Coverage for MitraClip
Includes patients with secondary (or functional) mitral regurgitation resulting from heart failure.Abbott Laboratories 01.20.21
-
Diagnostics
Abbott to Supply Additional 30M COVID-19 Tests to U.S. Gov't
Company is in final stages of completing its self-funded capacity expansion across U.S. manufacturing sites.PR Newswire 01.13.21
-
Diagnostics | Neurological
FDA OKs Abbott's First-of-Its-Kind Rapid, Handheld TBI Test
Produces a result within 15 minutes after a plasma sample is inserted.Abbott Laboratories 01.11.21
-
Diagnostics
FDA Authorizes Abbott's Rapid, $25 COVID-19 Test for At-Home Use
Telehealth service will take users step-by-step through the sample collection process.U.S. Food and Drug Administration 12.17.20
-
Diagnostics
Abbott's COVID-19 IgG Quantitative Antibody Test Wins EU Approval
Identifies levels of IgG antibodies that attach to the virus' spike protein.Abbott Laboratories 12.16.20
-
Cardiovascular
Abbott Launches OCT Virtual Reality Training for Cardiologists
VR training improved cath lab staff learning engagement by 45 percent, knowledge retention by 72 percent.Abbott Laboratories 12.09.20
-
Former Abbott Executive Appointed President of PQ Bypass
New leader has nearly 30 years of healthcare experience.Business Wire 11.13.20
-
Former Abbott Executive Joins Centricity Vision Board
New member has more than four decades of business and ophthalmology industry experience.Business Wire 11.11.20
-
Diagnostics
Abbott's COVID-19 IgM Test Receives EUA
Test demonstrated 99.56 percent specificity, 95 percent sensitivity for patients tested 15 days after symptom onset.Abbott Laboratories 10.12.20
-
Diagnostics
Abbott Shares ID NOW COVID-19 Interim Clinical Study Results
ID NOW performance of 95 percent sensitivity, 97.9 percent specificity within seven days of symptom onset.Abbott Laboratories 10.07.20
-
J&J, Abbott Medical Executive Named Chief Commercial Officer at WaveFront Dynamics
Latest hire brings more than 20 years of medical device business experience to the position.Business Wire 10.02.20
-
Chronic Disease
Abbott's FreeStyle Libre 3 Receives CE Mark
Features world's smallest, thinnest sensor with best-in-class performance at the same low cost for people with diabetes.PR Newswire 09.28.20
-
Cardiovascular
Abbott’s MitraClip G4 Receives CE Mark
Offers physicians an innovative system with more options for mitral valve repair using proven clip-based technology.Abbott 09.21.20
-
Patient Monitoring
Abbott Introduces World's First Glucose Biosensor Designed for Athletes
The firm is collaborating with Supersapiens in launch of the Libre Sense Glucose Sport Biosensor in Europe.PR Newswire 09.18.20
-
Cardiovascular
Abbott Begins Study for New Esprit BTK Fully Resorbable Stent
Will evaluate bioresorbable device to treat blocked arteries below the knees.PR Newswire 09.03.20
-
Diagnostics
Feds to Buy $760M of Abbott's $5, 15-Minute COVID-19 Test
150 million tests, which require no lab equipment, will be strategically distributed to where they’re needed most.HHS.gov U.S. Department of Health & Human Services 08.28.20
-
Diagnostics
FDA Grants EUA to Abbott's $5, 15-Minute, COVID Antigen Test
Company will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October.PR Newswire 08.27.20
-
Cardiovascular
Abbott Begins Study Evaluating New Device to Treat Recurrent AFib
Study will evaluate the performance of the investigational TactiFlex Ablation Catheter, Sensor Enabled.PR Newswire 08.07.20
-
Abbott Vascular Executive Assumes Chief Medical Officer Role at Abiomed
Harvard-educated doctor spent nearly three decades as an interventional cardiologist.Business Wire 08.07.20
-
Former Abbott Labs Exec is Named COO at Inspire Medical Systems
New hire spent a decade at Abbott Laboratories in various roles.Globe Newswire 08.05.20
-
Digital Health
FDA OKs Abbott’s iOS-Compatible Therapy Management App
App allows people living with chronic pain and movement disorders to personalize therapy via their mobile device.PR Newswire 07.23.20
-
-
Abbott Agrees to Settlement with Edwards Lifesciences
All disputes related to transcatheter mitral and tricuspid repair products have been resolved.PRNewswire 07.14.20
-
Cardiovascular
FDA Approves Abbott's Next-Gen Gallant ICDs, CRT-Ds
The devices feature Bluetooth connectivity and continuous remote monitoring.PR Newswire 07.06.20
-
Chronic Disease
Abbott's Freestyle Libre 2 iCGM Cleared in U.S. For Adults and Children with Diabetes
Automatically alerts users when their glucose is high or low without needing to scan the sensor.PRNewswire 06.15.20
-
Former Abbott Executive Recruited as Chief Commercial Officer at Endologix
New hire has more than a decade of experience in the medical device industry.Business Wire 06.11.20
-
How Are MPO’s Top 30 Addressing COVID-19?
J&J's Janssen moves the start of its Phase 1/2a vaccine clinical trial from September to the first half of July.Online Exclusives Sam Brusco, Associate Editor 06.09.20
-
Diagnostics
Abbott Buries N.Y. Study with Positive ID NOW COVID-19 Test Results
Urgent care clinic study shows performance of ≥94.7 percent positive agreement compared to PCR test.Abbott Laboratories 05.22.20
-
Diagnostics
FDA Warns About Possible Accuracy Concerns With Abbott Coronavirus Test
Agency claims ID NOW may return false negative results; Abbott says some studies are investigating the test's role in ways it was not meant to be used.PR Newswire 05.15.20
-
Diagnostics
Abbott Earns EUA for COVID-19 Molecular Test on Alinity m System
Ths system runs up to 1,080 tests in 24 hours.PR Newswire 05.13.20
-
Diagnostics
Abbott’s COVID-19 Antibody Blood Test Gains EUA for Use on Alinity i System
Plans to ship nearly 30 million antibody tests globally in May across its Architect and Alinity i platforms.PR Newswire 05.11.20
-
Cardiovascular
BIOTRONIK's Ultrathin Strut Drug-Eluting Stent Outperforms Abbott's Xience
Company's stent has been used to treat more than 2 million patients worldwide to date.PR Newswire 05.01.20
-
Medtech Execs Named to White House Economic Task Force
Will provide recommendations on how best to safely reopen U.S. economy in the wake of the COVID-19 pandemic.AdvaMed 04.15.20
-
Diagnostics
Abbott Launches COVID-19 Antibody Blood Test
Abbott begins shipping April 16 and intends to distribute 4 million tests in April.PR Newswire 04.15.20
-
Cardiovascular
Abbott's TriClip Transcatheter Tricuspid Valve Repair Gains CE Mark
The device is delivered to the "forgotten heart valve" through the femoral vein in the leg.Abbott 04.09.20
-
Chronic Disease | Patient Monitoring
FDA OKs Abbott's FreeStyle Libre CGM Use in Hospitals
Remotely monitors patients with diabetes to minimize exposure to COVID-19.PR Newswire 04.08.20
-
Mike on Medtech: COVID-19, Part 1
Mike Drues and Sean Fenske discuss Emergency Use Authorization and the potential problems with non-medical device manufacturers producing ventilators.Sean Fenske, Editor-in-Chief 04.01.20
